A subscription to JoVE is required to view this content. Sign in or start your free trial.
Here we describe two protocols: first to propagate, extract, purify, and quantify large quantities of honey bee non-enveloped virus particles, including a method for removing honey bee pupae and second to test the effects of viral infection using a highly repeatable, high-throughput cage bioassay.
Honey bees are of great ecological and agricultural importance around the world but are also subject to a variety of pressures that negatively affect bee health, including exposure to viral pathogens. Such viruses can cause a wide variety of devastating effects and can often be challenging to study due to multiple factors that make it difficult to separate the effects of experimental treatments from preexisting background infection. Here we present a method to mass produce large quantities of virus particles along with a high throughput bioassay to test viral infection and effects. Necessitated by the current lack of a continuous, virus-free honey bee cell line, viral particles are amplified in vivo using honey bee pupae, which are extracted from the hive in large volumes using minimally stressful methodology. These virus particles can then be used in honey bee cage bioassays to test inocula viability, as well as various other virus infection dynamics, including interactions with nutrition, pesticides, and other pathogens. A major advantage of using such particles is that it greatly reduces the chances of introducing unknown variables in subsequent experimentation when compared to current alternatives, such as infection via infected bee hemolymph or homogenate, though care should still be taken when sourcing the bees, to minimize background virus contamination. The cage assays are not a substitute for large-scale, field-realistic experiments testing virus infection effects at a colony level, but instead function as a method to establish baseline viral responses that, in combination with the semi-pure virus particles, can serve as important tools to examine various dimensions of honey bee-virus physiological interactions.
Honey bees (Apis mellifera) play a critical role in the modern global agricultural landscape but are currently suffering from a combination of biotic and abiotic stressors, including pesticide exposure, poor forage, parasites, and pathogens1,2. One of the most important pathogens of concern are viruses, many of which are vectored by another of the major honey bee stressors, the parasitic Varroa mite (Varroa destructor). These viruses can cause an array of negative effects in honey bees including reduced brood survival, developmental defects, and paralysis that can lead to total hive collapse ....
1. Mass bee extraction option 1: larval self-removal
Successfully following the protocols (Figures 1) for pupal injection and viral extraction should produce large quantities of virus particles. However, sampling and injecting pupae sourced from a variety of colonies at multiple time points maximizes the chances of acquiring target virus with low contamination. The dynamics by which viruses replicate and interact with one another within a honey bee is not well understood; coupled with the likelihood for preexisting infection, there is no guarantee that the.......
Here we have outlined methods detailing every step of the virus amplification and inoculum stock preparation process, including larvae collection and virus propagation, extraction, and concentration, as well as viral treatment in the form of cage-feeding experiments. These methods allow for production of semi-pure virus particles (Figure 4), the effectiveness of which can be consistently be quantified by dose-response mortality testing for viruses that are lethal to adults (
We would like to thank Dr. Julia Fine for her ideas and discussion during the protocol creation process, as well as Dr. Cassondra Vernier for her helpful comments throughout editing. These materials contributed towards projects that were supported in part by the Foundation for Food and Agriculture Research, under grant ID 549025.
....Name | Company | Catalog Number | Comments |
10% bleach solution | |||
24:1 chloroform:isoamyl alcohol | SigmaAldrich | C0549 | |
70% ethanol solution | |||
Cages for bioassay | Dependent on experimental setup | ||
Combitips Advanced 0.1 mL | Eppendorf | 30089405 | Optional (if no injector appartus is available) |
Containers for larval self-removal | Should measure roughly 19" x 9-1/8" (Langstroth deep frame dimensions) | ||
Forceps | Blunt, soft forceps for larval separationl; blunt, hard forceps for pupal excision | ||
Fume hood | |||
Incubator | Capable of maintaining 34 ºC and 50% relative humidity | ||
Kimwipes | Fisher Scientific | 06-666 | Any absorbent wipe will work |
Medium-sized weight boats | Serve as inoculum trays | ||
Microcon-100kDa with Biomax membrane | MilliporeSigma | MPE100025 | |
NaCl | |||
Nitrile gloves | |||
Phosphate buffered saline (PBS) | SigmaAldrich | P5119 | |
Polyethylene glycol 8000 (PEG) | SigmaAldrich | 1546605 | |
Refrigerated benchtop centrifuge | Capable of 15,000 x g | ||
Refrigerated centrifuge | Capable of 21,000 x g | ||
Repeater M4 Multipipette | Eppendorf | 4982000322 | Optional (if no injector appartus is available) |
RNAse Away | ThermoFisher | 7000TS1 | |
RNAse-free water | SigmaAldrich | W4502 | |
Sucrose | |||
TES | SigmaAldrich | T1375 |
This article has been published
Video Coming Soon
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved